267 related articles for article (PubMed ID: 26302801)
1. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease.
Xicota L; Rodriguez-Morato J; Dierssen M; de la Torre R
Curr Drug Targets; 2017; 18(2):174-195. PubMed ID: 26302801
[TBL] [Abstract][Full Text] [Related]
2. Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG).
Singh NA; Mandal AK; Khan ZA
Nutr J; 2016 Jun; 15(1):60. PubMed ID: 27268025
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster.
Martinez-Perez DA; Jimenez-Del-Rio M; Velez-Pardo C
Neurotox Res; 2018 Oct; 34(3):401-416. PubMed ID: 29667128
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.
Pervin M; Unno K; Ohishi T; Tanabe H; Miyoshi N; Nakamura Y
Molecules; 2018 May; 23(6):. PubMed ID: 29843466
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age.
Payne A; Nahashon S; Taka E; Adinew GM; Soliman KFA
Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327563
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
8. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.
Gonçalves PB; Sodero ACR; Cordeiro Y
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065606
[TBL] [Abstract][Full Text] [Related]
9. Natural Polyphenols in the Treatment of Alzheimer's Disease.
Syarifah-Noratiqah SB; Naina-Mohamed I; Zulfarina MS; Qodriyah HMS
Curr Drug Targets; 2018; 19(8):927-937. PubMed ID: 28356027
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
Kim CY; Lee C; Park GH; Jang JH
Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of EGCG: a patent review.
Chakrawarti L; Agrawal R; Dang S; Gupta S; Gabrani R
Expert Opin Ther Pat; 2016 Aug; 26(8):907-16. PubMed ID: 27338088
[TBL] [Abstract][Full Text] [Related]
13. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
Mandel S; Weinreb O; Amit T; Youdim MB
J Neurochem; 2004 Mar; 88(6):1555-69. PubMed ID: 15009657
[TBL] [Abstract][Full Text] [Related]
14. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
Weinreb O; Mandel S; Amit T; Youdim MB
J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate for Parkinson's disease.
Sergi CM
Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1029-1041. PubMed ID: 35748799
[TBL] [Abstract][Full Text] [Related]
16. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.
Smith A; Giunta B; Bickford PC; Fountain M; Tan J; Shytle RD
Int J Pharm; 2010 Apr; 389(1-2):207-12. PubMed ID: 20083179
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review.
Khalifa MKA; Abdel-Sattar SA; Amin OM; Kohaf NA; Zaky HS; Abd El-Fattah MA; Mohammed KHA; Badawi NM; Mansoor I; Eassa HA
Daru; 2024 Jun; 32(1):319-337. PubMed ID: 38079104
[TBL] [Abstract][Full Text] [Related]
18. The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection.
Khalatbary AR; Khademi E
Nutr Neurosci; 2020 Apr; 23(4):281-294. PubMed ID: 30043683
[TBL] [Abstract][Full Text] [Related]
19. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG).
Mandel SA; Amit T; Kalfon L; Reznichenko L; Weinreb O; Youdim MB
J Alzheimers Dis; 2008 Oct; 15(2):211-22. PubMed ID: 18953110
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
